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Background: The present review investigated which findings in vascular imaging 
techniques can be used to predict clinical outcome and the risk of symptomatic intrace-
rebral hemorrhage (sICH) in patients who underwent intravenous thrombolytic treatment.
Methods: Publications were searched, and the inclusion criteria were as follows: (1) 
published manuscripts, (2) patients with acute ischemic stroke managed with intrave-
nous recombinant tissue plasminogen activator (rtPA), and (3) availability of imaging 
assessment to determine vessel patency or the regulation of cerebral blood flow prior 
to, during, and/or after thrombolytic treatment. Clinical outcomes were divided into 
neurological outcome [National Institutes of Health Stroke Scale (NIHSS) within 7 days] 
and functional outcome (modified Rankin score in 2–3 months). sICH was defined as 
rtPA-related intracerebral bleeding associated with any worsening of NIHSS.
Results: Thirty-nine articles were selected. Recanalization was associated with improved 
neurological and functional outcomes (OR = 7.83; 95% CI, 3.71–16.53; p < 0.001 and 
OR = 11.12; 95% CI, 5.85–21.14; p < 0.001, respectively). Both tandem internal carotid 
artery/middle cerebral artery (ICA/MCA) occlusions and isolated ICA occlusion had 
worse functional outcome than isolated MCA occlusion (OR = 0.26, 95% CI, 0.12–0.52; 
p < 0.001 and OR = 0.24, 95% CI, 0.07–0.77; p = 0.016, respectively). Reocclusion was 
associated with neurological deterioration (OR = 6.48, 95% CI, 3.64–11.56; p < 0.001), 
and early recanalization was associated with lower odds of sICH (OR = 0.36, 95% CI, 
0.18–0.70; p = 0.003).
Conclusion: Brain circulation data before, during, and after thrombolysis may be useful 
for predicting the clinical outcome. Cerebral arterial recanalization, presence and site of 
occlusion, and reocclusion are all important in predicting the clinical outcome.
Keywords: ischemic stroke, clinical outcome, intracerebral hemorrhage, cerebral hemodynamics, intracranial 
circulation, cerebral autoregulation, rtPA
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iNTRODUCTiON
A meta-analysis of recombinant tissue plasminogen activator 
(rtPA) trials suggested that there may be a group of patients 
who would benefit from thrombolysis within 6 h of symptom 
onset, if they were carefully selected using advanced imaging 
modalities (1).
There has been an extensive investigation of prognostic 
indices of good outcomes that can be applied before, during, and 
after thrombolysis (2). It is well known that factors, such as age, 
initial National Institutes of Health Stroke Scale (NIHSS) score, 
and systolic blood pressure, are of predictive value for clinical 
outcome and symptomatic intracerebral hemorrhage (sICH) (3). 
Magnetic resonance imaging (MRI), computed tomography (CT), 
and transcranial Doppler (TCD) have also been used as possible 
prognostic determinant tools (4). In particular, arterial occlu-
sion, recanalization, and reocclusion, among other factors, have 
been investigated in terms of outcome prediction (4). However, 
there is a gap in the literature about how many methods, which 
evaluate intracranial circulation, have been used before and after 
thrombolysis to predict the outcome in a systematic fashion, 
together with a critical review of the strengths and weaknesses 
of each method.
The aim of the present review is (1) to undertake a descriptive 
systematic review of studies that have evaluated the intracranial 
circulation before, during, and after thrombolysis; (2) to evaluate 
the parameters that provide prognostic information of clinical 
outcome and/or sICH; and (3) to perform a meta-analysis of 
studies that used such parameters.
MATeRiALS AND MeTHODS
Search Strategy
A literature search strategy, restricted to publications from 
January 1994 to January 2015, was designed to identify cerebral 
hemodynamic studies, which assessed cerebral vessel patency 
and/or autoregulation in acute ischemic stroke patients treated 
with intravenous rtPA. Two reviewers (Ricardo C. Nogueira 
and Nazia P. Saeed) identified studies from PubMed database 
using the keywords “ischemic stroke” AND “rtPA treatment” 
OR “thrombolysis” AND “cerebral hemodynamics” OR “cerebral 
autoregulation” OR “cerebral blood flow control.” Bibliographic 
references of selected articles were examined for additional 
suitable studies. The inclusion criteria were (1) published manu-
scripts in English language, (2) patients (>18 years of age) with 
acute ischemic stroke treated with intravenous rtPA, and (3) 
availability of assessment of intracranial circulation to determine 
vessel patency and/or regulation of cerebral blood flow prior 
to, during, and/or after thrombolytic treatment. The exclusion 
criteria were (1) acute ischemic stroke not managed with intra-
venous rtPA, (2) impossibility to determine the vessel patency or 
the regulation of cerebral blood flow before, during, and/or after 
rtPA administration, (3) non-English language publications, (4) 
non-human models, and (5) case reports. The systematic review 
followed PRISMA guidelines; quality assessment of articles were 
used applying the American Academy of Neurology rating system 
by two raters (Ricardo C. Nogueira and Nazia P. Saeed), reviewed 
by a third investigator (Edson Bor-Seng-Shu) in terms of agree-
ment, and this individual resolved any discrepancies. For the 
meta-analysis, authors of publications with incomplete data were 
contacted for additional information. Moreover, care was taken 
to exclude articles with no comparable data (for example: lack of 
imaging after thrombolysis, lack of clinical outcome measured, 
etc.) and articles with patients included in other articles from the 
same institution to avoid biasing the population sample.
Data extraction
The following data were extracted from each article: sample size, 
presence of a control group, type(s) of diagnostic modality used, 
time delay between assessment and thrombolysis (when stated), 
time interval between rtPA treatment and monitoring examina-
tions (assessment during and following treatment, when stated), 
outcomes, conclusions, and study limitations. The articles were 
grouped according to the method of cerebral hemodynamic 
assessment. Data from cerebral hemodynamic assessment tech-
niques were compared based on their common aspects, primary 
contributions, and limitations.
Outcomes
Clinical outcomes were divided into functional, defined by modi-
fied Rankin scale (mRS) in the late post-thrombolytic therapy 
(2–3 months) with good outcome been considered as mRS ≤2, 
and neurological outcomes, assessed by NIHSS and comprising 
improvement (reduction of 10 points or final NIHSS ≤3) or 
deterioration (increase ≥4 points) in the early post-thrombolytic 
therapy stage (within 7 days). sICH was defined as rtPA-related 
intracerebral bleeding detected by CT or MRI associated with any 
worsening of NIHSS or death. Additional outcome measures were 
arterial recanalization assessed by different scales [thombolysis 
in brain ischemia (TIBI), thrombolysis in myocardial ischemia 
(TIMI), and partial or full recanalization], reocclusion (within 
24 h), and cerebral infarct volume.
Meta-analysis
The variables related to assessment of intracranial circulation were 
identified in each retrieved paper and, if they presented in the 
results a significant correlation with clinical outcome and sICH in 
a multivariate analysis, they were considered for the meta-analysis. 
The software used for meta-analysis was the OpenMetaAnalyst 
(Center for Evidence-based Medicine, Brown University School of 
Public Health – Providence, RI, USA), the binary random-effect 
method was applied, and the heterogeneity of studies was evaluated 
using I2 statistics. To identify for publication bias, a funnel plot and 
Egger’s test were applied in the analysis of any assessed variable, 
where information was available from three or more studies.
ReSULTS
Number of Studies Retrieved
The search in PubMed retrieved 7369 articles. After analyzing the 
title and abstract, a total of 278 articles were deemed suitable. The 
inclusion and exclusion criteria were then applied, leaving 39 arti-
cles for further analysis (Figure 1). Each article was then grouped 
FiGURe 1 | Flow diagram of studies identification.
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according to the neuroimaging technique performed; 26 studies 
used TCD ultrasonography, 2 computed tomography angiography 
(CTA), 10 magnetic resonance imaging angiography (MRA), and 
1 either MRA or CTA. TCD ultrasonography was the most used 
method for cerebral hemodynamic evaluation and was, on average, 
performed on more patients per study, besides presenting the short-
est time interval for follow-up assessment (average 2.4 h).
Characteristics of the included Studies
There were 38 observational studies (37 cohort and 1 case-control) 
and 1 interventional study; no randomized controlled clinical trial 
was identified (please see Supplementary Material). The majority 
of the observational studies (36 of 38) used the neuroimaging 
methods for prognostic purposes, and the remainder used the 
methods for investigating diagnostic accuracy or causation.
After grouping the articles based on the type of cerebral hemo-
dynamic assessment, common findings were as follows.
MR/CT Angiography
Thirteen studies using CTA (2 studies), MRA (10 studies), or 
MRA + CTA (1 study) were included (please see Supplementary 
Material) (5–17). In two studies (one using MRA and another 
CTA), neuroimaging assessment was not performed after rtPA 
treatment. The mean time delay from neuroimaging examination 
to thrombolytic therapy was 40  min, and the mean time for a 
second exam following therapy was 19.2  h. One study had an 
interventional design, and the main outcomes were functional and 
recanalization (TIMI 1–3). rtPA was associated with higher rates 
of recanalization and better functional outcomes. Concerning 
the observational studies, the findings revealed that the presence, 
site of arterial occlusion [proximal middle cerebral artery (MCA), 
distal MCA, or tandem internal carotid artery (ICA)–MCA], and 
the occurrence of partial or full recanalization were related to the 
clinical outcomes and final infarct size. The limitations included 
a small sample size and difficulties in determining the time of 
arterial recanalization.
Transcranial Doppler
Twenty-six studies used TCD as a method for cerebral hemo-
dynamic assessment (please see Supplementary Material) 
(3,  18–42). In 24 studies, cerebral hemodynamic parameters 
were evaluated prior to and after thrombolytic treatment (range 
from 2  h to 2  days), while the remaining 2 studies presented 
only pre-rtPA cerebral hemodynamic data. TCD was the sole 
method for monitoring the cerebral hemodynamic status during 
thrombolysis.
These studies revealed that factors, such as pretreatment TIBI 
classification score, arterial recanalization/reocclusion, and the 
site of occlusion (tandem occlusions, proximal/distal ICA, or 
MCA occlusions), were associated with clinical outcome, infarct 
size, and sICH.
Limitations included the operator-dependence nature of the 
TCD method, the absence of arterial imaging resources (making 
it difficult to determine the site of occlusion), and unfavorable 
cranial windows for ultrasound energy passage.
Pooled Results
The cerebral circulation variables associated with functional and 
neurological outcomes or sICH were arterial recanalization/
reocclusion, presence/absence of arterial occlusion, and the 
site of occlusion (Tables 1 and 2). No article regarding cerebral 
autoregulation (CA) was identified.
For the meta-analysis, 23 out of 39 articles were excluded 
for the following reasons: possibility of overlapping patients 
(12 articles, 964 patients), lack of data able to be compared (6 
articles, 360 patients), and lack of success in obtaining additional 
data (5 articles, 129 patients). Arterial recanalization was sig-
nificantly associated with good functional outcome (OR = 11.12; 
95% CI, 5.85–21.14; p < 0.001) and neurological improvement 
(OR =  7.83; 95% CI, 3.71–16.53; p <  0.001) (Figures  2A,B). 
Both tandem ICA/MCA occlusions and isolated ICA occlusion 
had worse functional outcome than isolated MCA occlusion 
(OR  =  0.26, 95% CI, 0.12–0.52; p  <  0.001 and OR  =  0.24, 
95% CI, 0.07–0.77; p =  0.016, respectively) (Figures  2C1,C2). 
Patients with recanalization followed by reocclusion within 24 h 
of thrombolysis had significant association with neurological 
deterioration (overall OR: 6.48, 95% CI: 3.64–11.56, p < 0.001) 
(Figure 2D). Early recanalization (up to 2 h after thrombolysis) 
was associated with lower odds of sICH (overall OR = 0.36, 95% 
CI, 0.18–0.70; p = 0.003) (Figure 3).
The funnel plots of functional outcomes and sICH were sug-
gestive of potential publication bias, which was confirmed by the 
Egger’s test (intercept: 43.65, p = 0.046; intercept: 1.97, p = 0.003; 
Figures 4A,B, respectively). However, the funnel plot of neuro-
logical improvement did not indicate the publication bias (Egger’s 
test intercept: 1.48, p = 0.83; Figure 4C).
DiSCUSSiON
In 2003, Schellinger et  al. (43) highlighted the importance of 
various diagnostic modalities, such as brain MRI, CT, and TCD 
FiGURe 2 | Meta-analysis of hemodynamic variables related to clinical outcome. (A) Functional outcome (dichotomized mRS) in recanalized versus 
non-recanalized patients. (B) Neurological outcome (NIHSS) in recanalized versus non-recanalized patients. (C) Functional outcome (dichotomized mRS) by site of 
occlusion: (C1) tandem ICA–MCA versus isolated MCA and (C2) isolated ICA versus isolated MCA. (D) Clinical deterioration in recanalization versus reocclusion 
patients. MCA – middle cerebral artery, ICA – internal carotid artery, NIHSS – National Institute of Health Stroke Scale, and mRS – modified Rankin scale.
TABLe 2 | Studies demonstrating association with symptomatic intracerebral hemorrhage.
Article Method variable Outcome Result
Saqqur et al. (36) TCD Persistence of occlusion ≥2 h sICH OR = 6 (1.5–21.3) p = 0.01
Saqqur et al. (36) TCD Recanalization beyond 24 h or persistent occlusion sICH OR = 3 (1.1–10) p = 0.04
Saqqur et al. (36) TCD Persistence of proximal occlusion at 2 h sICH OR = 5 (1.5–15) p = 0.008
Saqqur et al. (36) TCD Persistence of proximal occlusion at 2 h (excluding reocclusion) sICH OR = 8 (3–26) p < 0.001
TABLe 1 | Studies demonstrating association with clinical outcome.
Article Method variable Outcome Result





Recanalization NIHSS at day 60 Multiple linear regression 
p = 0.0001
Molina et al. (3) TCD Proximal occlusion before thrombolysis Good outcome (mRS ≤2) in 90 days OR = 0.25 (0.10–0.61) p < 0.001
Sims et al. (17) CTA Absence of occlusion Early improvement (4 points in NIHSS) OR = 5.0 (1.1–23.3) p = 0.04
Sims et al. (17) CTA Absence of occlusion Good outcome (mRS ≤2) in 7 days OR = 6.8 (1.3–34.6) p = 0.02
Saqqur et al. (42) TCD Reocclusion Clinical deterioration (4 points in NIHSS) OR = 4.9 (1.7–13) p = 0.002
Saqqur et al. (41) TCD Distal × proximal MCA occlusion before 
thrombolysis
Good outcome (mRS ≤1) in 90 days OR = 2.1 (1.1–4) p = 0.025
Tsivgoulis et al. (34) TCD Recanalization within 2 h Good outcome (mRS ≤2) in 90 days OR = 5.98 (2.58–13.84) p < 0.001
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ultrasonography, for the decision-making process regarding 
thrombolytic therapy for acute ischemic stroke. Furthermore, 
the assessment of cerebral hemodynamic during and after throm-
bolytic therapy may be important to determine the parameters 
that could influence the clinical outcome, especially in the face 
of new research investigating the aggressive control of ABP in 
this scenario (44). Finally, with the new guidelines regarding 
endovascular treatment (45), the evaluation of cerebral circula-
tion will be useful to determine proximal occlusion and also 
could select patients who were excluded from endovascular 
trials, but could benefit from the interventional therapy. To our 
knowledge, the present paper is the first to use techniques of 
systematic review and meta-analysis to verify the influence of 
assessment of intracranial circulation, provided by brain MRI, 
FiGURe 4 | Funnel plot assessing publication bias: (A) Functional outcome (dichotomized mRS) in recanalized versus non-recanalized patients; 
(B) Symptomatic intracranial hemorrhage in recanalization versus non-recanalization; and (C) Neurological outcome (NiHSS) in recanalized versus 
non-recanalized patients. NIHSS – National Institute of Health Stroke Scale and mRS – modified Rankin scale.
FiGURe 3 | Meta-analysis of the hemodynamic variables recanalization versus non-recanalization related to symptomatic intracerebral hemorrhage.
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CT, and TCD ultrasonography on clinical outcomes and sICH 
in acute ischemic stroke patients who underwent thrombolytic 
therapy (46).
Considering the hemodynamic studies reviewed here, the 
specific details of each study are worth emphasizing. MRA and 
CTA represent valuable options for detecting and confirming 
large vessel occlusion, but cannot identify the timing of reca-
nalization (8, 11, 15, 16, 37, 47–49). Furthermore, early imaging 
changes are the strong predictors of sICH (50) and could be used 
in association with cerebral circulation parameters. The primary 
6Nogueira et al. Intracranial Circulation Parameters in Ischemic Stroke
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limitations of MRA and CTA studies were the time delay in 
assessment after thrombolytic treatment, the use of intravenous 
contrast media, and the difficulties in determining the timing of 
recanalization (6, 9, 12, 48, 49). However, it is well established 
that the presence and timing of brain arterial recanalization 
correlates with clinical outcome, hemorrhagic complications, 
and infarct size (14, 19–22, 25, 29, 31, 36, 37). For this purpose, 
TCD ultrasonography remains a valuable choice, as this method 
exhibits the following advantages: (1) device portability, (2) low 
cost of the method, and (3) real-time monitoring during throm-
bolysis (3, 18, 20–23, 25, 26, 30, 34, 36, 37). TCD ultrasound 
may also play a therapeutic role during thrombolysis; a recent 
systematic review revealing that sonothrombolysis associated 
with rtPA is a safe procedure that increases recanalization rate 
in the acute ischemic stroke setting (51, 52). However, TCD is 
operator-dependent, cannot reliably monitor small brain artery 
occlusion, and does not determine the exact site of occlusion. 
Therefore, in the future, a combination of methods may be 
important.
Only variables that, in the retrieved papers, presented signifi-
cant correlation with outcome (clinical or sICH) in a multivariate 
analysis were included in the present review. The main variables 
associated with clinical outcome or sICH were recanalization, 
reocclusion, and the presence and site of occlusion. Our meta-
analysis showed that recanalization is significantly associated 
with functional and neurological outcomes, but not with sICH. 
In fact, some studies have shown that the time of recanalization 
is associated with neurological recovery (21), and the persistence 
of occlusion is associated to sICH (36). Our findings are in agree-
ment with a previous meta-analysis, which found significant 
association between recanalization and clinical outcome (OR: 
4.43) and no association between recanalization and sICH, but 
comparisons should be made with caution because the previous 
meta-analysis evaluated intravenous, intra-arterial, and mechani-
cal therapies (53).
Most of the conclusions presented in this paper have already 
been presented in endovascular therapy (EVT) trials. However, 
some issues, such as reocclusion, are more suitable for investi-
gation by non-invasive imaging techniques. Furthermore, we 
believe that the information gathered in this paper, reaffirming 
the conclusions obtained with EVT trials and pointing the positive 
and negative aspects of other imaging techniques, is important to 
support the utilization of multimodality imaging in stroke care. 
A multimodality approach may provide a better understanding 
of the natural evolution of this pathology, and perhaps better 
future selection of patients for interventional therapies, who 
are currently excluded. Finally, strengthening the importance of 
different imaging modalities in the intravenous therapy setting is 
important for centers that still do not have access to interventional 
therapy, especially in low-income countries.
There are few studies concerning CA during acute and suba-
cute ischemic stroke. Existing publications on CA in ischemic 
stroke reveal a transient impairment of CA during the subacute 
stages of major ischemic stroke (54–57). Interestingly, using 
animal models, it has been demonstrated that rtPA displays 
neurotoxic properties that can disrupt the blood–brain barrier, 
damage vessels, and possibly impair the CA (58). To our knowl-
edge, only one study of CA after rtPA treatment in humans is 
available, which concluded that this treatment does not contrib-
ute to impaired CA. However, this study evaluated CA 10–20 h 
after rtPA treatment; not eliminating the possibility of an initial 
detrimental effect by rtPA on CA (59).
The limitations of the current review are (1) the search strategy 
was restricted to just one database, although PubMed comprises 
a majority of the relevant articles on this topic; (2) the inclu-
sion criteria were limited to research of standard dose of rtPA 
(0.9 mg/kg) for thrombolysis, although low dose of rtPA (0.6 mg/
kg), other thrombolytic drugs (desmoteplase or tenecteplase), or 
other methods (mechanical thrombectomy, intra-arterial rtPA) 
have been investigated; (3) lack of analysis concerning the effect 
of recanalization time on clinical outcome, although the present 
meta-analysis showed the clinical impact of recanalization at the 
first 24 h; (4) use of different imaging modalities for detecting 
arterial occlusion and recanalization; (5) data heterogeneity 
(especially number of patients included in each study, quality of 
study, and average stroke severity) from different publications; 
and (6) potential publication bias of some outcomes’ measures 
confirmed by the funnel plot and Egger’s test.
CONCLUSiON
In conclusion, the use of brain assessments of cerebral circula-
tion before, during, and after rtPA thrombolysis is promising, 
especially, to predict outcome. Arterial recanalization, presence 
and site of occlusion, and reocclusion relate to clinical outcome. 
Future studies of prognostic accuracy should investigate these 
factors, ideally using more than one method of cerebral hemody-
namic assessment. In addition, the evaluation of cerebral blood 
flow regulation mechanisms during and after rtPA treatment 
should be explored.
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